EUDA Health Holdings Ltd EUDA

FY2025 · ended Dec 31, 2025 · Revenue $6.82M, +70.0% YoY · Filed Apr 28, 2026

EUDA Health Holdings Ltd (EUDA) files with the SEC under industry code 8000, Services-Health Services. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $6.8 million and a net loss of $2.8 million. Free cash flow was -$2.5 million. As of Dec 31, 2025 it held $345,145 in cash and investments and $200,698 in total debt.

Revenue
$6.82M
+70.0% vs prior year
Net income
$-2.77M
+81.9% vs prior year
Operating cash flow
$-2.43M
-19.3% vs prior year
Free cash flow
$-2.50M
-17.5% vs prior year
EPS
$-1.48
+84.4% vs prior year
Dividend per share
None
Shares outstanding
1.89M
-94.9% vs prior year
Net cash
$144,447
FY 2025
Operating margin
-36.3%
FY 2025

Company profile

Industry
Services-Health Services (SIC 8000)
Listed as
EUDA (Nasdaq), EUDAW (Nasdaq)
Fiscal year ends
December 31
Incorporated in
Virgin Islands, British
Headquarters
Eunos Techpark
SEC filer status
Non-accelerated filer, Emerging growth company
SEC CIK
1847846
Former names
8i Acquisition 2 Corp. (until Nov 17, 2022)

Other Services-Health Services companies

Key figures

Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.

Line
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2022
Jul 31, 2022
Revenue
$6.8M
$4.0M
$3.7M
$3.8M
—
Operating income
-$2.5M
-$17.3M
-$4.0M
-$12.2M
-$2.0M
Net income
-$2.8M
-$15.4M
-$10.0M
-$24.9M
-$1.8M
Diluted EPS
-$1.48
-$9.46
-$8.77
—
—
Operating cash flow
-$2.4M
-$2.0M
-$2.9M
-$1.5M
-$1.0M
Free cash flow
-$2.5M
-$2.1M
—
-$1.5M
—
Total assets
$1.7M
$1.7M
$1.3M
$25.6M
$86.8M
Total liabilities
$6.0M
$4.3M
$8.8M
$29.1M
$4.7M
Stockholders' equity
-$4.3M
-$2.6M
-$7.5M
-$3.5M
-$3.7M
Cash and investments
$345,145
$237,605
—
—
$193,546
Total debt
$200,698
$231,176
$201,958
$102,160
—

Recent SEC filings

Recent SEC filings
Form Description Filed Period
6-K Current report (foreign issuer) Nov 3, 2026 Oct 31, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Oct 13, 2026 Oct 13, 2026
6-K Current report (foreign issuer) Sep 29, 2026 Jun 30, 2026
6-K Current report (foreign issuer) Aug 26, 2026 Aug 26, 2026
6-K Current report (foreign issuer) Jul 31, 2026 Jul 31, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.